Reverse transcriptase inhibitors for treating adenocarcinomas
US5223490A · kind A · utility
4Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 1990 |
| Grant date | Jun 29, 1993 |
| Priority date | — |
| Expiry date | Jul 5, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A reverse transcriptase inhibitor such as 3'-azido-3-deoxythymidine is used for the treatment or prophylaxis of a retrovirus-associated carcinoma such as breast cancer in a human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.